These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11064494)

  • 1. Interactions between methadone and medications used to treat HIV infection: a review.
    Gourevitch MN; Friedland GH
    Mt Sinai J Med; 2000; 67(5-6):429-36. PubMed ID: 11064494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone and antiretroviral medications, part II.
    Gourevitch MN; Friedland GH
    AIDS Clin Care; 1999 May; 11(5):37, 43, 45-6. PubMed ID: 11367102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    McCance-Katz EF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and antiretroviral medications, part I.
    Gourevitch MN; Friedland GH
    AIDS Clin Care; 1999 Apr; 11(4):30-1 contd. PubMed ID: 11366210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
    Dubé MP; Parker RA; Mulligan K; Tebas P; Robbins GK; Roubenoff R; Grinspoon SK
    Clin Infect Dis; 2007 Jul; 45(1):120-6. PubMed ID: 17554712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
    Bruce RD; McCance-Katz E; Kharasch ED; Moody DE; Morse GD
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S216-23. PubMed ID: 17109308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.
    Clarke SM; Mulcahy FM; Tjia J; Reynolds HE; Gibbons SE; Barry MG; Back DJ
    Clin Infect Dis; 2001 Nov; 33(9):1595-7. PubMed ID: 11568856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment.
    Gilbert L; El-Bassel N; Rajah V; Foleno A; Fontdevila J; Frye V; Richman BL
    Mt Sinai J Med; 2000; 67(5-6):452-64. PubMed ID: 11064497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.
    Galynker II; Watras-Ganz S; Miner C; Rosenthal RN; Des Jarlais DC; Richman BL; London E
    Mt Sinai J Med; 2000; 67(5-6):381-7. PubMed ID: 11064488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone and anti-HIV drugs.
    Fornataro K
    Body Posit; 1999 May; 12(5):13. PubMed ID: 11366305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.
    Bruce RD; Altice FL; Gourevitch MN; Friedland GH
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):563-72. PubMed ID: 16652030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Information on methadone].
    Harley R
    Sidahora; 2001 Aug; ():23. PubMed ID: 11681270
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
    Brown LS; Kritz S; Chu M; Madray C
    J Subst Abuse Treat; 2006 Jun; 30(4):331-5. PubMed ID: 16716848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.